3D Printing of Pediatric Medication: The End of Bad Tasting Oral Liquids?-A Scoping Review

Iris Lafeber, Elisabeth J Ruijgrok, Henk-Jan Guchelaar, Kirsten J M Schimmel

Research output: Contribution to journalReview articleAcademicpeer-review

34 Citations (Scopus)
37 Downloads (Pure)

Abstract

3D printing of pediatric-centered drug formulations can provide suitable alternatives to current treatment options, though further research is still warranted for successful clinical implementation of these innovative drug products. Extensive research has been conducted on the compliance of 3D-printed drug products to a pediatric quality target product profile. The 3D-printed tablets were of particular interest in providing superior dosing and release profile similarity compared to conventional drug manipulation and compounding methods, such as oral liquids. In the future, acceptance of 3D-printed tablets in the pediatric patient population might be better than current treatments due to improved palatability. Further research should focus on expanding clinical knowledge, providing regulatory guidance and expansion of the product range, including dosage form possibilities. Moreover, it should enable the use of diverse good manufacturing practice (GMP)-ready 3D printing techniques for the production of various drug products for the pediatric patient population.

Original languageEnglish
Article number416
JournalPharmaceutics
Volume14
Issue number2
DOIs
Publication statusPublished - 14 Feb 2022

Bibliographical note

Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.

Fingerprint

Dive into the research topics of '3D Printing of Pediatric Medication: The End of Bad Tasting Oral Liquids?-A Scoping Review'. Together they form a unique fingerprint.

Cite this